CBX7 and central nervous system cancer: Pyrosequencing revealed that the methylation rate of CBX7 was higher in glioma cells (Fig. 7K), and clinical sample tests also showed that the methylation rate of CBX7 was higher in cancer tissues compared to adjacent non-cancerous tissues (Fig. 7L).